Related Experiment Videos
[Malignant Caroli's disease. Etiopathogenic hypotheses, apropos a case]
A Lobato Muñoz1, S Ortiz Reina, J Baquedano Rodríguez
1Servicio de Cirugía General, Hospital Militar Central Gómez Ulla, Madrid.
Revista Espanola De Enfermedades Digestivas
|April 1, 1991
Summary
Caroli's disease significantly increases cholangiocarcinoma risk, over 100 times higher than the general population. Early surgical intervention is recommended due to the disease's progressive nature.
Area of Science:
- Hepatology and Gastroenterology
- Oncology
- Medical Case Reports
Background:
- Caroli's disease is a rare congenital disorder characterized by cystic dilatation of the intrahepatic bile ducts.
- Malignant transformation, particularly cholangiocarcinoma, is a known complication of Caroli's disease.
Observation:
- A case report details Caroli's disease with concurrent cholangiocarcinoma in a 30-year-old female.
- This highlights the potential for early-onset complications in this condition.
Findings:
- The risk of malignancy in Caroli's disease is estimated at 7-12%, with cholangiocarcinoma being the most common histopathologic type.
- The incidence of cholangiocarcinoma in Caroli's disease is substantially elevated compared to the general population.
Implications:
- The high frequency suggests a potential premalignant or carcinogenic agent associated with Caroli's disease.
- Resective surgery is advised when feasible, as the risk of malignant degeneration correlates with disease duration.